NYSEAMERICAN:CRHM - CRH Medical Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$3.10 -0.05 (-1.59 %)
(As of 07/20/2018 04:00 PM ET)
Previous Close$3.10
Today's Range$3.10 - $3.20
52-Week Range$1.46 - $3.75
Volume6,911 shs
Average Volume82,859 shs
Market Capitalization$229.48 million
P/E RatioN/A
Dividend YieldN/A
Beta1.14
CRH Medical logoCRH Medical Corporation provides various products and services to gastroenterologists for the treatment of gastrointestinal diseases in the United States, Canada, and internationally. It offers CRH O'Regan system, a single use, disposable, and hemorrhoid banding technology for treating various grades of hemorrhoid. The company also offers anesthesia services for patients undergoing endoscopic procedures. It distributes the CRH O'Regan system, treatment protocols, and operational and marketing expertise as a turnkey package directly to gastroenterology practices. The company was formerly known as Medsurge Medical Products Corp. and changed its name to CRH Medical Corporation in April 2006. CRH Medical Corporation was founded in 2000 and is headquartered in Vancouver, Canada.

Receive CRHM News and Ratings via Email

Sign-up to receive the latest news and ratings for CRHM and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN
Industry Medical Instruments & Supplies
Sub-IndustryN/A
SectorMedical
SymbolNYSEAMERICAN:CRHM
CUSIPN/A
Phone+1-604-6331440

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding Shares72,850,000
Market Cap$229.48

CRH Medical (NYSEAMERICAN:CRHM) Frequently Asked Questions

What is CRH Medical's stock symbol?

CRH Medical trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "CRHM."

How were CRH Medical's earnings last quarter?

CRH Medical Corp (NYSEAMERICAN:CRHM) released its quarterly earnings results on Monday, April, 30th. The company reported $0.02 EPS for the quarter, topping the consensus estimate of ($0.01) by $0.03. The firm had revenue of $24.67 million for the quarter, compared to the consensus estimate of $21.70 million. View CRH Medical's Earnings History.

When is CRH Medical's next earnings date?

CRH Medical is scheduled to release their next quarterly earnings announcement on Wednesday, August, 1st 2018. View Earnings Estimates for CRH Medical.

What price target have analysts set for CRHM?

5 equities research analysts have issued 1 year target prices for CRH Medical's stock. Their predictions range from $5.00 to $5.00. On average, they expect CRH Medical's stock price to reach $5.00 in the next year. This suggests a possible upside of 61.3% from the stock's current price. View Analyst Ratings for CRH Medical.

What is the consensus analysts' recommendation for CRH Medical?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CRH Medical in the last year. There are currently 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy."

Are investors shorting CRH Medical?

CRH Medical saw a drop in short interest in the month of June. As of June 29th, there was short interest totalling 131,994 shares, a drop of 56.8% from the June 15th total of 305,717 shares. Based on an average trading volume of 24,493 shares, the days-to-cover ratio is presently 5.4 days. View CRH Medical's Current Options Chain.

Who are some of CRH Medical's key competitors?

Who are CRH Medical's key executives?

CRH Medical's management team includes the folowing people:
  • Mr. Edward Wright, CEO & Non-Independent Director (Age 55)
  • Mr. Richard K. Bear, CFO & Corp. Sec. (Age 55)
  • Mr. James Kreger, Pres of CRH Anesthesia Management
  • Ms. Kettina Cordero, Director of Investor Relations
  • Dr. Mitchel Guttenplan M.D., FACS, Medical Director

Has CRH Medical been receiving favorable news coverage?

Media stories about CRHM stock have trended somewhat positive recently, according to Accern. The research firm identifies negative and positive media coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. CRH Medical earned a news sentiment score of 0.10 on Accern's scale. They also gave media stories about the company an impact score of 45.03 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company's share price in the next few days.

How do I buy shares of CRH Medical?

Shares of CRHM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is CRH Medical's stock price today?

One share of CRHM stock can currently be purchased for approximately $3.10.

How big of a company is CRH Medical?

CRH Medical has a market capitalization of $229.48 million.

How can I contact CRH Medical?

CRH Medical's mailing address is 57B - 999 Canada Place World Trade Center, VANCOUVER, BC V6C 3E1, Canada. The company can be reached via phone at +1-604-6331440.


MarketBeat Community Rating for CRH Medical (NYSEAMERICAN CRHM)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  119 (Vote Outperform)
Underperform Votes:  99 (Vote Underperform)
Total Votes:  218
MarketBeat's community ratings are surveys of what our community members think about CRH Medical and other stocks. Vote "Outperform" if you believe CRHM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CRHM will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.